• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

OpGen

edit

OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications.

OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.

Recent Milestones

edit

• 
  OpGen — OpGen Announces Partnership with University of California, Davis, to Develop High Resolution Microbial Genetic Maps in Support of The 100K Genome Project (12/19/12)
  Posted 2/20/13 at 3:59am via opgen.com
• 
  OpGen invested in BioRelix. (3/22/12)
  Posted 3/22/12 at 6:19pm via masshightech.com
• 
  OpGen received $17M in Venture Round funding. (3/7/12)
  Posted 3/12/12 at 6:15pm via finsmes.com
• 
  OpGen — OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales (2/9/11)
  Posted 2/8/11 at 7:57pm via dowjones.com
• 
  OpGen received $17M in Series B funding. (9/28/10)
  Posted 9/27/10 at 9:41pm via opgen.com
• 
  OpGen received $2M in Debt funding. (12/11/09)
  Posted 12/11/09 at 5:30pm via sec.gov
• 
  OpGen added Evan Jones as Interim CEO. (12/1/09)
  Posted 12/11/09 at 5:30pm
• 
  OpGen received $23.6M in Series A funding. (9/12/07)
  Posted 3/12/10 at 3:50am via opgen.com
• 
  OpGen added Ronald Lennox as Chairman.
  Posted 12/11/09 at 5:30pm
• 
  OpGen added Corey Mulloy as Director.
  Posted 12/11/09 at 5:30pm
• 
  OpGen added Bijan Salehizadeh, MD as Director.
  Posted 12/11/09 at 5:30pm
• 
  OpGen added Trevor D'Souza as Observer.
  Posted 12/11/09 at 5:30pm
• 
  OpGen added Douglas White as CEO.
  Posted 2/20/13 at 3:52am
• 
  OpGen added Eric Winzer as CFO.
  Posted 2/20/13 at 3:52am

Videos

Screenshots

edit

Above: OpGen
Uploaded: 3/12/10

Sources

1. Connecticut biotech raises $2.56M round (masshightech.com) [edit]
2. OpGen Announces $23.6 Million Series A Financing (opgen.com) [edit]
3. SEC D (sec.gov) [edit]
4. OpGen Completes $17 Million Series B Financing (opgen.com) [edit]
5. OpGen to Receive up to $17M in Financing (finsmes.com) [edit]
OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales (fis.dowjones.com) [edit]
OpGen Announces Partnership with University of California, Davis, to Develop High Resolution Microbial Genetic Maps in Support of The 100K Genome Project (opgen.com) [edit]